BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kadkhoda J, Akrami-Hasan-Kohal M, Tohidkia MR, Khaledi S, Davaran S, Aghanejad A. Advances in antibody nanoconjugates for diagnosis and therapy: A review of recent studies and trends. Int J Biol Macromol 2021;185:664-78. [PMID: 34224755 DOI: 10.1016/j.ijbiomac.2021.06.191] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Mansour W, El Fedawy SF, Atta SA, Zarie RM, Fouad NTA, Maher S, Hussein TM, Abdel Aziz DM, Kamel M. Targeted therapy for HCC using dumbbell-like nanoparticles conjugated to monoclonal antibodies against VEGF and cancer stem cell receptors in mice. Cancer Nano 2023;14:14. [DOI: 10.1186/s12645-023-00163-0] [Reference Citation Analysis]
2 Kang Y, Li S. Nanomaterials: Breaking through the bottleneck of tumor immunotherapy. Int J Biol Macromol 2023;230:123159. [PMID: 36610572 DOI: 10.1016/j.ijbiomac.2023.123159] [Reference Citation Analysis]
3 Hong W, Lou B, Gao Y, Zhao H, Ying S, Yang S, Li H, Yang Q, Yang G. Tumor microenvironment responded naturally extracted F(O)F1-ATPase loaded chromatophores for antitumor therapy. Int J Biol Macromol 2023;230:123127. [PMID: 36603722 DOI: 10.1016/j.ijbiomac.2022.123127] [Reference Citation Analysis]
4 Zhao Z, Fang L, Lv D, Chen L, Zhang B, Wu D. Design and synthesis of Ag NPs/chitosan-starch nano-biocomposite as a modern anti-human malignant melanoma drug. Int J Biol Macromol 2023;236:123823. [PMID: 36842739 DOI: 10.1016/j.ijbiomac.2023.123823] [Reference Citation Analysis]
5 Samantasinghar A, Sunildutt NP, Ahmed F, Soomro AM, Salih ARC, Parihar P, Memon FH, Kim KH, Kang IS, Choi KH. A comprehensive review of key factors affecting the efficacy of antibody drug conjugate. Biomed Pharmacother 2023;161:114408. [PMID: 36841027 DOI: 10.1016/j.biopha.2023.114408] [Reference Citation Analysis]
6 Li X, An S, Wang C, Jiang Q, Gao D, Wang L. Protein-polysaccharides based nanoparticles for loading with Malus baccata polyphenols and their digestibility in vitro. Int J Biol Macromol 2023;228:783-93. [PMID: 36581037 DOI: 10.1016/j.ijbiomac.2022.12.236] [Reference Citation Analysis]
7 Sharma P, Kaur N, Shanavas A. Targeting strategies using PLGA nanoparticles for efficient drug delivery. Poly(Lactic-Co-glycolic Acid) (PLGA) Nanoparticles for Drug Delivery 2023. [DOI: 10.1016/b978-0-323-91215-0.00016-9] [Reference Citation Analysis]
8 Cândido M, Vieira P, Campos A, Soares C, Raniero L. Gold-Coated Superparamagnetic Iron Oxide Nanoparticles Functionalized to EGF and Ce6 Complexes for Breast Cancer Diagnoses and Therapy. Pharmaceutics 2022;15. [PMID: 36678728 DOI: 10.3390/pharmaceutics15010100] [Reference Citation Analysis]
9 Meivita MP, Lee D, Naikar JS, Go SX, Teoh WC, Tan YS, Bajalovic N, Loke DK. An Efficient, Short Stimulus PANC-1 Cancer Cell Ablation and Electrothermal Therapy Driven by Hydrophobic Interactions. Pharmaceutics 2022;15. [PMID: 36678734 DOI: 10.3390/pharmaceutics15010106] [Reference Citation Analysis]
10 Siminzar P, Tohidkia MR, Eppard E, Vahidfar N, Tarighatnia A, Aghanejad A. Recent Trends in Diagnostic Biomarkers of Tumor Microenvironment. Mol Imaging Biol 2022. [DOI: 10.1007/s11307-022-01795-1] [Reference Citation Analysis]
11 Marshall SK, Saelim B, Taweesap M, Pachana V, Panrak Y, Makchuchit N, Jaroenpakdee P. Anti-EGFR Targeted Multifunctional I-131 Radio-Nanotherapeutic for Treating Osteosarcoma: In Vitro 3D Tumor Spheroid Model. Nanomaterials (Basel) 2022;12. [PMID: 36234645 DOI: 10.3390/nano12193517] [Reference Citation Analysis]
12 Bhattacharjee R, Kumar L, Mukerjee N, Anand U, Dhasmana A, Preetam S, Bhaumik S, Sihi S, Pal S, Khare T, Chattopadhyay S, El-Zahaby SA, Alexiou A, Koshy EP, Kumar V, Malik S, Dey A, Proćków J. The emergence of metal oxide nanoparticles (NPs) as a phytomedicine: A two-facet role in plant growth, nano-toxicity and anti-phyto-microbial activity. Biomed Pharmacother 2022;155:113658. [PMID: 36162370 DOI: 10.1016/j.biopha.2022.113658] [Reference Citation Analysis]
13 Sun J, Zhao H, Xu W, Jiang G. Recent advances in photothermal therapy-based multifunctional nanoplatforms for breast cancer. Front Chem 2022;10:1024177. [DOI: 10.3389/fchem.2022.1024177] [Reference Citation Analysis]
14 Wang D, Cui Q, Yang YJ, Liu AQ, Zhang G, Yu JC. Application of dendritic cells in tumor immunotherapy and progress in the mechanism of anti-tumor effect of Astragalus polysaccharide (APS) modulating dendritic cells: a review. Biomed Pharmacother 2022;:113541. [PMID: 36127221 DOI: 10.1016/j.biopha.2022.113541] [Reference Citation Analysis]
15 Cano-Garrido O, Serna N, Unzueta U, Parladé E, Mangues R, Villaverde A, Vázquez E. Protein scaffolds in human clinics. Biotechnol Adv 2022;61:108032. [PMID: 36089254 DOI: 10.1016/j.biotechadv.2022.108032] [Reference Citation Analysis]
16 Böldicke T. Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future Directions. Antibodies 2022;11:49. [DOI: 10.3390/antib11030049] [Reference Citation Analysis]
17 Jin Y, Edalatian Zakeri S, Bahal R, Wiemer AJ. New Technologies Bloom Together for Bettering Cancer Drug Conjugates. Pharmacol Rev 2022;74:680-711. [PMID: 35710136 DOI: 10.1124/pharmrev.121.000499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Mohaghegh S, Tarighatnia A, Omidi Y, Barar J, Aghanejad A, Adibkia K. Multifunctional Magnetic Nanoparticles for MRI-guided Co-delivery of Erlotinib and L-Asparaginase to Ovarian Cancer. J Microencapsul 2022;:1-31. [PMID: 35748819 DOI: 10.1080/02652048.2022.2094487] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Kadkhoda J, Tarighatnia A, Tohidkia MR, Nader ND, Aghanejad A. Photothermal therapy-mediated autophagy in breast cancer treatment: Progress and trends. Life Sciences 2022;298:120499. [DOI: 10.1016/j.lfs.2022.120499] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
20 Aghanejad A, Bonab SF, Sepehri M, Haghighi FS, Tarighatnia A, Kreiter C, Nader ND, Tohidkia MR. A review on targeting tumor microenvironment: The main paradigm shift in the mAb-based immunotherapy of solid tumors. Int J Biol Macromol 2022;207:592-610. [PMID: 35296439 DOI: 10.1016/j.ijbiomac.2022.03.057] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
21 Xu G, Luo Y, Wang H, Wang Y, Liu B, Wei J. Therapeutic bispecific antibodies against intracellular tumor antigens. Cancer Lett 2022;:215699. [PMID: 35487312 DOI: 10.1016/j.canlet.2022.215699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Sato S. Protein Chemical Modification Using Highly Reactive Species and Spatial Control of Catalytic Reactions. Chem Pharm Bull (Tokyo) 2022;70:95-105. [PMID: 35110442 DOI: 10.1248/cpb.c21-00915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Sharma N, Bietar K, Stochaj U. Targeting nanoparticles to malignant tumors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022. [DOI: 10.1016/j.bbcan.2022.188703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
24 Kadkhoda J, Aghanejad A, Safari B, Barar J, Rasta SH, Davaran S. Aptamer-conjugated gold nanoparticles for targeted paclitaxel delivery and photothermal therapy in breast cancer. Journal of Drug Delivery Science and Technology 2022;67:102954. [DOI: 10.1016/j.jddst.2021.102954] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
25 Kadkhoda J, Tarighatnia A, Barar J, Aghanejad A, Davaran S. Recent advances and trends in nanoparticles based photothermal and photodynamic therapy. Photodiagnosis Photodyn Ther 2021;37:102697. [PMID: 34936918 DOI: 10.1016/j.pdpdt.2021.102697] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
26 Saravanakumar K, Anbazhagan S, Pujani Usliyanage J, Vishven Naveen K, Wijesinghe U, Xiaowen H, Vishnu Priya V, Thiripuranathar G, Wang MH. A comprehensive review on immuno-nanomedicine for breast cancer therapy: Technical challenges and troubleshooting measures. Int Immunopharmacol 2021;103:108433. [PMID: 34922248 DOI: 10.1016/j.intimp.2021.108433] [Reference Citation Analysis]
27 Tarighatnia A, Abdkarimi MH, Nader ND, Mehdipour T, Fouladi MR, Aghanejad A, Ghadiri H. Mucin-16 targeted mesoporous nano-system for evaluation of cervical cancer via dual-modal computed tomography and ultrasonography. New J Chem 2021;45:18871-80. [DOI: 10.1039/d1nj04123a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]